CSIMarket
V F Corporation  (VFC)
Other Ticker:  
 
 
Price: $70.8200 $-0.91 -1.269%
Day's High: $73.81 Week Perf: -6.32 %
Day's Low: $ 73.09 30 Day Perf: -3.16 %
Volume (M): 180 52 Wk High: $ 90.79
Volume (M$): $ 13,253 52 Wk Avg: $79.62
Open: $72.96 52 Wk Low: $65.34



 Market Capitalization (Millions $) 27,904
 Shares Outstanding (Millions) 394
 Employees 48,000
 Revenues (TTM) (Millions $) 10,947
 Net Income (TTM) (Millions $) 1,225
 Cash Flow (TTM) (Millions $) -545
 Capital Exp. (TTM) (Millions $) 310

V F Corporation
VF Corporation, through its operating subsidiaries, designs, manufactures and sources and markets branded jeanswear, sportswear, intimate apparel, outdoor apparel and equipment, occupational apparel and other apparel. VF Corporation, organized in 1899, oversees the operations of its individual businesses, providing them with financial and administrative resources.


   Company Address: 1551 Wewatta Street Denver 80202 CO
   Company Phone Number: 778-4000   Stock Exchange / Ticker: NYSE VFC
   VFC is expected to report next financial results on February 01, 2022. Next quarterly dividend pay out on December 20, 2021.


Customers Net Income fell by VFC's Customers Net Profit Margin fell to

-56.08 %

8.35 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
COLM   -100%    
LEVI   -100%    
NKE   -0.73%    
RL        0.03% 
SKX   -100%    
UA   -5.28%    
• View Complete Report
   



Artelo Biosciences Inc

Sales and Earnings Unchanged

In the financial period ending Aug 31 2021 Artelo Biosciences Inc reached break-even of $-0.00 per share compared to $-0.27 a year ago and from $-0.11 per share from the previous quarter.

Artelo Biosciences Inc reported operating shortfall of $-3.186884 millions, in the financial period ending Aug 31 2021, a deterioration from the operating shortfall of $-0.951395 millions, realized in fourth quarter of 2020
Artelo Biosciences Inc reported net loss of $-7.44 millions and Sales of $0.00 millions for the fiscal year 2021.

Company has decreased loss per share to $-0.40 from $-1.26 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

Lexaria Bioscience Corp

Deficit Bigger Than a Year Ago, Topline Tumbles

Lexaria Bioscience Corp reported disastrous fourth quarter of 2021, where Sales faded by -78.66% to $0.03 millions and loss per share has widen to $-0.22, from the same quarter a year ago.

from the preceding quarter from $-0.50 per share, by -86.01% from $0.20 millions.
Lexaria Bioscience Corp reported net loss of $-3.87 millions and Sales of $0.72 millions for the fiscal year 2021.

Net loss per share has widen to $-0.95 from $-0.05 in previous fiscal year, while Sales surged by 84 % from $0.39 millions a year ago.

Construction Partners Inc

Despite Very Strong Sales EPS Fell

Construction Partners Inc announced earnings per share of $0.15 and Sales of $261.66 millions in the fourth quarter of 2021, Company's earnings per share plummeted by -55.12% per share, versus $0.34 eps, earned in the same quarter a year ago, although Construction Partners Inc saw its Sales rise by 24.21% in the same period.

Sequentially profits fell by -15.3% from $0.18 per share and Sales increased by 6.64 % from $261.66 millions.
In the fiscal year 2021, Construction Partners Inc reported Sales of $910.74 millions and net income of $20.18 millions.

Income per share faded by -50 % to $0.39 per share from $0.78 in the previous fiscal year, while Sales improved by 15.92 % from $785.68 millions a year ago.

Nutra Pharma Corp

Nutra Pharma Corp announced most recent fiscal period operating loss of $-0.51231 millions

Nutra Pharma Corp recorded operating loss of $-0.51231 millions, in the most recent fiscal period, a degradation from the operating shortfall of $-0.186753 millions, reported in third quarter of 2020

Sales jumped by 44.08% to $0.02 millions from $0.01 millions in the same quarter a year ago and sequentially Sales Tumbled by -36.75% from $0.03 millions.

Polarityte Inc

Polarityte Inc announced fiscal third quarter of 2021 operating shortfall of $-7.41 millions

In the fiscal third quarter of 2021 Polarityte Inc decreased loss of $-0.01 per share compared to $-0.18 a year ago and improved from $-0.04 per share from the previous quarter.

Sales fell sharply by -66.56% to $1.12 millions from $3.34 millions in the same quarter a year ago and sequentially Sales Tumbled by -56.01% from $2.54 millions.






 

V F's Segments
 
Jeanswear
 Segment    20.7 % of total Revenue
Outdoor Apparel & Equipment
 Segment    63.57 % of total Revenue
Other
 Segment    0.88 % of total Revenue
Imagewear
 Segment    8.07 % of total Revenue
Sportswear
 Segment    4.48 % of total Revenue
Contemporary Brands
 Segment    2.3 % of total Revenue
 
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADMP's Profile

Stock Price

ADMP's Financials

Business Description

Fundamentals

Charts & Quotes

ADMP's News

Suppliers

ADMP's Competitors

Customers & Markets

Economic Indicators

ADMP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071